Enjuvia gets U.S. regulatory approval
Barr Pharmaceuticals received U.S. regulatory approval for a new female hormone replacement
product called Enjuvia. The plant-derived product was approved by the FDA for the treatment
of moderate to severe vasomotor symptoms associated with menopause.